Gazette Tracker
Gazette Tracker

Core Purpose

Corrects dosage form and strength of Azithromycin in Hindi version of Notification S.O. 659(E) regarding ceiling price revision.

Detailed Summary

This corrigendum, issued by the National Pharmaceutical Pricing Authority under the Ministry of Chemicals and Fertilizers, addresses an error in the Hindi version of notification S.O. 659(E) dated 7th February 2025. The original notification concerned the revision of ceiling price based on a review order. Specifically, the correction pertains to the entry for Azithromycin at Sl. No. 1, column (3). It mandates that in the Hindi version, the dosage form and strength should be amended from “गोली 500 मिलीग्राम” (Tablet 500mg) to “गोली 250 मिलीग्राम” (Tablet 250mg).

Full Text

REGD. No. D. L.-33004/99 The Gazette of India CG-DL-E-20022025-261201 EXTRAORDINARY PART II-Section 3-Sub-section (ii) PUBLISHED BY AUTHORITY No. 903] NEW DELHI, THURSDAY, FEBRUARY 20, 2025/PHALGUNA 1, 1946 MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) CORRIGENDUM New Delhi, the 20th February, 2025 S.O. 910(E). In the National Pharmaceutical Pricing Authority's notification S.O. 659(E) of 7th February 2025 published in the Gazette of India, Extraordinary relating to revision of ceiling price based on review order, in Hindi version, the dosage form and strength in column (3) for Entry at Sl. No. 1 related to Azithromycin shall be read as "Tablet 250mg" in place of "Tablet 500mg". [PN/261/129/2025/F/F. No. 8(129)/2025/D.P./NPPA-Div.-II] MAHAVEER SAINI, Dy. Director

Never miss important gazettes

Create a free account to save gazettes, add notes, and get email alerts for keywords you care about.

Sign Up Free